Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Aducanumab: appropriate use recommendations update
The Journal of Prevention of Alzheimer's Disease · Vol. 9, pp. 221-230 Published January 1, 2022
More on these topics
Browse all publications →-
2025 · CNS Drugs
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer’s Disease: Synthesis of Evidence from Observational and Interventional Trials
-
2025 · Journal of Alzheimer’s Disease
Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial
-
2023 · Alzheimers Res Ther
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review